The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: Report of a synergistic effect between topotecan and radiation Article

cited authors

  • Lamond, JP; Mehta, MP; Boothman, DA

fiu authors

publication date

  • October 1, 1996

keywords

  • BETA-LAPACHONE
  • Clinical Neurology
  • DNA TOPOISOMERASE
  • HUMAN-TUMOR-CELLS
  • Life Sciences & Biomedicine
  • Oncology
  • PHASE-I
  • POISON CAMPTOTHECIN
  • Science & Technology
  • glioma
  • topoisomerase I
  • topotecan

volume

  • 30